You are on page 1of 6

Accelerat ing t he world's research.

Otitis externa in dogs: microbiology


and antimicrobial susceptibility
I. Tsachev

Related papers Download a PDF Pack of t he best relat ed papers 

ISOLAT ION AND IDENT IFICAT ION OF MICROORGANISMS PRESENT IN 53 DOGS SUFFERING OT …
amrie ramirez

Isolat ion and ident ificat ion of microorganisms present in 53 dogs suffering ot it is ext erna
Roger Ramirez-Barrios

Updat e on ant imicrobial suscept ibilit ies of bact erial isolat es from canine and feline ot it is ext erna
Lorraine Lund
Otitis externa in dogs: microbiology and
antimicrobial susceptibility

V. PETROV1*, G. MIHAYLOV1, I.TSACHEV1, G. ZHELEV1, P. MARUTSOV1, K. KOEV1


1
Department of Veterinary Microbiology, Infectious and Parasitic Diseases, Faculty of Veterinary Medicine, Trakia University, 6000 Stara Zagora, BULGARIA

*Corresponding author: vlado72@abv.bg

SUMMARY RESUME
he aims of the study were to determine the prevalence of bacterial/yeast Otite externe chez le chien: analyse microbiologique et résistance aux
otitis externa in dogs and to analyse antimicrobial susceptibility. Among antibiotiques
257 swab ear samples from Bulgarian dogs with otitis externa, bacteria
and yeast species were isolated in 93.77% of cases as mono-infections Les objectifs de cette étude ont été de déterminer la prévalence des otites
(109 cases) involving mainly coagulase positive staphylococci (60 strains), externes bactériennes ou mycosiques chez le chien et d’établir la résistance
Malassezia pachidermatis (97 strains) and Pseudomonas aeruginosa (42 des germes aux antibiotiques. Parmi les 257 prélèvements auriculaires
strains) and more oten as poly-infections (132 cases). he other agents réalisés sur des chiens atteints d’otite externe en Bulgarie, des bactéries
scarcely identiied were β-haemolytic Streptococcus spp., Proteus mirabilis ou des levures ont été mises en évidence dans 93.77% des cas, sous forme
and Escherichia coli, the 2 last species being almost exclusively found in de mono-infections (109 cas) principalement dues à des staphylocoques
poly-infections. he sensitivity of isolated bacteria to antimicrobial drugs, coagulase + (60 souches), à Malassezia pachidermatis (97 souches) et à
most commonly used treatment of otitis externa has been tested. he Pseudomonas aeruginosa (42 souches), et le plus souvent sous forme de
high sensitivity to beta-lactams and aminoglycoside-aminocyclitols was poly-infections (132 cas). Les autres agents plus rarement identiiés ont été
established in Gram positive bacteria, while Gram negative bacteria were des streptocoques β-hémolytiques, Proteus mirabilis et Escherichia coli, les
sensitive to aminoglycoside-aminocyclitols, polymyxin B and enroloxacin. 2 dernières espèces étant presqu’exclusivement retrouvées dans des cas de
hese results highlight the relative high frequency of yeasts and the necessity poly-infections. La sensibilité des isolats aux diférents antimicrobiens les
of coupling antimicrobial susceptibility tests to bacterial isolation. plus couramment utilisés dans le traitement des otites externes du chien
a été évaluée  : les bactéries Gram + ont montré une forte sensibilité aux
Keywords : Otitis externa, dogs, bacterial isolation, β-lactames et aux aminoglycosides / aminocyclitols alors que les bactéries
Gram – ont surtout été sensibles aux aminoglycosides / aminocyclitols, à
yeast, antimicrobial susceptibility.
la polymyxine B et à l’enroloxacine. Ces résultats soulignent la fréquence
relativement élevée des levures et la nécessité de déterminer la résistance aux
antibiotiques des germes en parallèle de leur isolement.

Mots-clés: Otite externe, chien, isolation bactérienne,


levures, résistance aux antibiotiques.

Introduction progressing pathological alterations (hyperplasia, oedema,


ibrosis  [17]. he normal ear canal microlora consists
Otitis externa is an acute or chronic inlammation of the of coagulase-positive, coagulase-negative Staphylococcus
external ear. he disease is more frequent in dogs than in cats. spp., β-haemolytic Streptococcus spp., Pr. mirabilis, E. coli,
Dogs with long pendulous ears are most commonly afected Ps. aeruginosa etc. he last agent is isolated in only 1% of
[2]. Ear infections are among the ten most frequent reasons healthy dogs and in up to 20% of dogs with chronic otitis
for dogs to be presented to veterinarians and may afect up externa [7, 18]. In healthy feline ears, Pasteurella multocida
to 20% of dogs [1, 6]. A number of predisposing factors are could be also isolated. Apart these bacterial agents, M.
identiied such as anatomical ear canal stenosis, hair in the ear pachidermatis, Microsporum canis and Otodectes cynoti could
canal, pendulous ears, haired concave side of ears, increased be also present without clinical signs of inlammation [5]. It
humidity (hinting dogs), moisture retention, washing, injury should be noticed that bacteria and yeasts are opportunists
during manipulations, foreign bodies, prolonged antibiotic and not primary pathogens causing solely otitis externa,
treatment, obstructive diseases (neoplasms) and systemic but they found a favourable medium for growth provided
conditions (immunosuppression) [17]. Other causes include that another cause is present [17, 18]. he successful
permanent factors such as bacteria (coagulase positive treatment of the disease requires appropriate medications
Staphylococcus spp., β-haemolytic Streptococcus spp., Proteus including anti-inlammatory drugs, antifungal agents and
mirabilis, Pseudomonas aeruginosa, Escherichia coli), yeasts chemotherapeutics in relation to the sensitivity of the
(Malassezia pachidermatis, Candida albicans), as well as aetiological agents [7, 9].

Revue Méd. Vét., 2013, 164, 1, 18-22


BACTERIAL OTITIS EXTERNA IN DOGS 19

he purpose of the present study was to determine the


microbial aetiological agents of canine otitis externa, their
prevalence and behaviour to antibacterial drugs that are
most commonly used for treatment of this disease.

Material and methods


ANIMALS AND SAMPLES

he study included 193 dogs from both genders, from Figure 1 : Number and distribution of microbial isolates (n = 388) from
dog ear secretion samples positive for microbiological agents (n = 241).
diferent breeds and from 8 months to 14 years old, all
with clinical signs speciic for otitis externa. Patients were
presented with unilateral or bilateral dropping of ears, head and 10% of dogs with bacterial otitis externa respectively.
shaking, pruritus, pain when palpated, erythema and swelling In addition, Pseudomonas aeruginosa and Proteus mirabilis
of ear skin or of ear canal with increased amount of cerumen. were isolated only from animals with chronic otitis or
A total of 257 samples of ear secretion were collected using from dogs that failed to respond to previous antibiotic
sterile cotton swabs. he study was performed between treatment. As already mentioned, the other bacterial species
January 2007 and December 2011. (β-haemolytic streptococci and E. coli) rarely caused otitis
externa independently, but were rather seen in association
MICROBIOLOGICAL TESTS with staphylococci or Pseudomonas aeruginosa.

Samples were cultivated on blood agar containing 5% Among the 241 positive samples for microbiological tests,
sheep blood (Bul-bio Base, National Institute of Parasitic and mono-infections were observed only in 109 samples (45.2%).
Infectious Diseases, Soia) and on McConkey agar (Difco). Coagulase-positive staphylococci were most commonly
Cultures were incubated aerobically for 24-48 hours at 37°C. identiied when a single organism was isolated from otitis
Mycological tests included aerobic cultivation of the samples patients corresponding to 60 cases (25% of all diseased dogs)
on Sabouraud dextrose agar (supplemented with 0.4 g/L followed by M. pachidermatis in 31 cases (13%). he other
chloramphenicol and 0.5 g/L cyclohexamide) for 2-7 days at bacterial species (β-haemolytic streptococci, E. coli and
37°C. Ater incubation, isolates were identiied according to Pseudomonas aeruginosa) rarely caused mono-infections,
conventional microbiological methods [16]. only in 11, 2 and 5 cases, respectively. By contrast, Proteus
mirabilis was not detected as a sole agent of canine otitis.
he behaviour of isolates to antimicrobial drugs was
tested by the disk difusion method and the results were Two and multiple microbial species were isolated from
interpreted by the three-score system of Bauer et al. [3], 132 samples: 119 samples with 2 microbial species, 11 with
as per requirements of NCCLS [14]. Disks loaded with 3 germs and 2 with 4 pathogens (Table I). he most frequent
antimicrobial drugs: amoxicillin/clavulanic acid (20/10 µg), microbial species involved in poly-infections were again
ampicillin/cloxacillin (6.69/18.31 µg), gentamicin (10 µg), Coagulase positive Staphylococcus spp (109/132, i.e. 82.58%),
tobramycin (10 µg), amikacin (30 µg), enroloxacin (5 µg), Malassezia pachidermatis (50.00%) and Pseudomonas
chloramphenicol (30 µg), doxycycline (30 µg), lincomycin/ aeruginosa (28.03%). However, among the species scarcely
spectinomycin (9 / 100 µg), and polymyxin B (10 µg) were isolated in bacterial otitis externa, Proteus mirabilis and E.
used. coli were oten associated with other germs in 100% and

infections with the b-haemolytic Streptococcus spp. and of


92.86% of positive samples whereas the proportions of mono-
Results
poly-infections involving them remained roughly similar
he microbiological tests conducted on 257 samples (44% and 56%, respectively). Animals with 3 or 4 microbial
showed that only 16 did not contain pathogenic agents simultaneously isolated exhibited chronic otitis.
microorganisms. From the other 241 samples, 388 microbial
agents were isolated. heir distribution by species is shown on he behaviour of bacterial isolates to tested antibacterial
igure 1. Coagulase-positive staphylococci were the prominent drugs is summarized in Table II. he analysis of strains
species, representing 43.6% of the microbial agents identiied behaviour towards antibiotics showed preserved high
and were found in more than 70% (169/241) of dogs with sensitivity to β-lactam combinations amoxicillin/
bacterial otitis externa. Malassezia pachidermatis represented clavulanic acid and ampicillin/cloxacillin in staphylococci
25% of the identiied germs and was isolated in 40% of and streptococci. Similar behaviour was exhibited by
patients whereas Pseudomonas aeruginosa (17%), Proteus Gram + bacteria towards aminoglycoside-aminocyclitols
mirabilis, Escherichia coli and β-haemolytic streptococci gentamicin, amikacin and tobramycin, with percentage
were more rarely observed and were isolated in 17%, 11% of sensitive strains between 74% and 91%. With regard

Revue Méd. Vét., 2013, 164, 1, 18-22


20 PETROV (V.) AND COLLABORATORS

Bacterial / yeast associations Number and frequency (%)


2 species
Malassezia pachidermatis 43 (17.84%)
Pseudomonas aeruginosa 21 (8.71%)
Coagulase positive
Proteus mirabilis 15 (6.22%)
Staphylococcus spp
Escherichia coli 10 (4.15%)
β-haemolytic Streptococcus spp. 10 (4.15%)

Escherichia coli 6 (2.49%)


Pseudomonas aeruginosa
Malassezia pachidermatis 5 (2.08%)
β-haemolytic Streptococcus spp. 3 (1.24%)

Escherichia coli Malassezia pachidermatis 6 (2.49%)


3-4 species
Proteus mirabilis / Malassezia pachidermatis 9 (3.73%)
Coagulase positive Staphylococ-
cus spp β-haemolytic Streptococcus spp. / Pseudomonas aeruginosa
1 (0.41%)
/ Escherichia coli

Proteus mirabilis / Malassezia pachidermatis 2 (0.83%)


Escherichia coli Proteus mirabilis / Malassezia pachidermatis / Pseudomo-
1 (0.41%)
nas aeruginosa

Table I : Distribution of microbial agents by species involved in co-infections (132 cases) in dogs with bacterial otitis externa cases (n = 241)

Staphylococcus
spp. Streptococcus spp. Pseudomonas
Proteus mirabilis Escherichia coli
Antibiotics (coagulase (β-haemolytic) aeruginosa
(n = 27) (n = 28)
positive) (n = 25) (n = 42)
(n = 169)
Amoxicillin-clavulanic acid 5% 5% 100% 30% 32%
Ampicillin/cloxacillin 19% 9% 100% 100% 100%
Gentamicin 20% 9% 2% 28% 18%
Tobramycin 26% 23% 20% 0% 5%
Amikacin 15% 21% 0% 0% 0%
Enroloxacin 32% 100% 38% 22% 14%
Chloramphenicol 40% 0% 100% 74% 0%
Doxycycline 49% 26% 100% 81% 22%
Lincomycin/Spectinomycin 59% 40% 40% 55% 0%
Polymyxin B 66% 100% 0% 74% 0%

Table II : Antibiotic resistance (%) of microbial agents isolated from dogs with bacterial otitis externa.

to enroloxacin, chloramphenicol and polymyxin B, the and E. coli strains were resistant to ampicillin/cloxacillin. At
sensitivity of staphylococci and streptococci was diferent. the same time, more than 2/3 of Proteus and E. coli isolates
All streptococcal isolates were resistant to enroloxacin while were sensitive to amoxicillin/clavulanic acid, whereas all
68% of staphylococci were sensitive. he opposite was true Pseudomonas isolates were resistant to this combination. he
for chloramphenicol: all streptococci were sensitive whereas resistance pattern to aminoglycosides was similar to that of
40% of staphylococci were resistant to this antibiotic. Some Gram + bacteria although the percentage of sensitive strains
staphylococci (34%) were sensitive to polymyxin B, but all was usually higher (ranging from 72% to 100%). he majority
streptococci were resistant. he sensitivity to tetracyclines as of Gram - bacteria was highly sensitive to enroloxacin (from
well as to the combination lincomycin/spectinomycin was 62% to 86%). All Pseudomonas and the majority of Pr.
higher for streptococci than for staphylococcal isolates. mirabilis strains were resistant to chloramphenicol (74%) and
tetracyclines (81%), while E. coli strains were highly sensitive.
Gram - bacteria showed a very diferent behaviour to Ps. aeruginosa and Pr. mirabilis isolates were oten resistant
beta-lactam combinations. All Ps. aeruginosa, Pr. mirabilis to lincomycin/spectinomycin (40% and 55% respectively)
Revue Méd. Vét., 2013, 164, 1, 18-22
BACTERIAL OTITIS EXTERNA IN DOGS 21

whereas all E. coli strains were sensitive. All Pseudomonas those of VANNI et al. [19] who has conducted a very detailed
and E. coli isolates were sensitive to the polypeptide antibiotic investigation on the resistance of Staphylococcus intermedius
polymyxin B while the sensitivity of Proteus spp. strains was and Staphylococcus schleiferi in Italy.
however low (< 20%).
he general opinion that Ps. aeruginosa is the most
Discussion resistant microbial agent involved in the aetiology of canine
otitis externa was also conirmed in the present study. Similar
In this study, 43.56% of all microbial isolates belonged to data are published by HARIHARAN et al. [8], demonstrating
the group of coagulase-positive staphylococci, among which 38% resistance to enroloxacin, 99% to chloramphenicol,
Staphylococcus intermedius (recently called Staphylococcus 98% to doxycycline but also a rather higher resistance to
pseudointermedius) and Staphylococcus aureus are already aminoglycoside-aminocyclitols gentamicin (15%) and
known as canine pathogens [7]. A survey of microbial agents amikacin (11%), contrary to present results (2% and 0%).
of canine otitis externa in Bulgaria was performed in the Nevertheless, ZAMANKHAN et al. [21] have obtained 100%
period 1993-1995 by BORISSOV et al. [4] that demonstrated resistance of Ps. aeruginosa strains to amoxicillin/clavulanic
the presence of coagulase-positive staphylococci in 54% of acid and lincomycin/spectinomycin combinations and 10%
all dogs with otitis. In this investigation, coagulase-positive to gentamicin and 0% to amikacin, which are closer to our
staphylococci were present both in mono- or co-infections observations. hey have also observed that 20% of isolates
in 70% of dogs with otitis externa. his prevalence is higher were sensitive to oxytetracycline and 30% to chloramphenicol
than that reported by BORISSOV et al. [4] and similar to whereas all isolates in the present study were resistance to
that found by HARIHARAN et al. [8], HARVEY et al. [9], these drugs. Others [13, 20] reported a higher resistance
LILENBAUM et al. [11], LYSKOVA et al. [12], and OLIVERA to aminoglycosides and luoroquinolones, consequently to
et al. [15]. ZAMANKHAN et al. [21] observed that 73.8% the frequent use of medications containing gentamicin and
of isolates in their study belonged to Staphylococcus spp. enroloxacin and recommended to replace them with other
vs. only 43.56% in ours. he authors have investigated the drugs from the same class as tobramycin and marboloxacin.
bacterial agents of otitis in a warmer climate (Iran) and
this is a probably cause for the higher prevalence observed. With regard to Pr. mirabilis and E. coli isolates, the current
Our data however are considerably diferent from those of results were highly similar to those of HARIHARAN et al.
BORNAND [5] who isolated S. intermedius in only 23% of [8] and ZAMANKHAN et al. [21].
canine otitis cases.
As a conclusion, it could be assumed that the commonest
he incidence of Gram - bacteria in the present study bacterial agents isolated from canine otitis externa were
was not very diferent from data reported in Bulgaria [4]: coagulase-positive staphylococci. It should be however
Ps. aeruginosa isolates were 9% of all strains vs. almost 11% remembered that yeasts are also frequently involved in
in this study. he study of BORISSOV et al. [4] did not the aetiology of ear canal inlammations and that in many
present data about the involvement of yeasts, but our data instances, clinical cases were caused by co-infections.
corresponded to those of BORNAND [5] in a similar setting Microbiological tests are always recommended for isolation
in Switzerland, where M. pachidermatis was isolated from and identiication of microbial agents and for determination
56% of dogs with otitis (40% in our study). With regard to of their sensitivity to chemotherapeutics used for treatment
this species, the present results were closer to those obtained of otitis externa in dogs.
by LYSKOVA et al. [12] in the Czech Republic. Prevalences
of Ps. aeruginosa, Pr. mirabilis and E. coli observed in the References
present study are similar to those reported by KROGH et al.
[10], LYSKOVA et al. [12] and OLIVERA et al. [15]. he last 1. ANGUS J.C.: Otic cytology in health and disease. Vet.
research group report also data about the incidence of co- Clin. Small. Anim., 2004, 34, 411-424.
infections and microbial species involved. heir results are 2. AUGUST J.R.: Otitis externa: a disease of multifactorial
similar to ours in that mixed infections occurred in more etiology. Vet. Clin. North Am. Small. Anim. Pract., 1988,
than half of diseased dogs. he combination Staphylococcus 18, 731-742.
intermedius + Malassezia pachidermatis was the most 3. BAUER A.W., KIRBY W.M., SHERRIS J.C., TURK M.:
commonly seen. Antibiotic susceptibility testing by a standardized single
disc method. Am. J. Clin. Pathol., 1966, 45, 493-496.
he sensitivity of staphylococci isolated from dogs 4. BORISSOV I., URUMOVA V., LYTZKANOV M.,
with otitis externa in the present study coincide with data GROSEVA V.: Clinical and microbiological studies in
of LILENBAUM et al. [11] with respect to ampicillin and dogs with otitis. Vet. Science, 1997, XXIX, 365-371.
gentamicin, except that the proportions of resistant strains to 5. BORNAND V.: Bacteriology and mycology of otitis
tetracyclines observed here was elevated (almost 50% vs. 7% in externa in dogs. Schweiz Arch. Tierheilkd., 1992, 134,
their study). he results in the present study on staphylococci 341-348.
resistance to amoxicillin/clavulanic acid, gentamicin, 6. COLE L.K.: Otoscopic evaluation of the ear canal. Vet.
amikacin and enroloxacin are also highly comparable to Clin. Small Anim., 2004, 34, 397-410.

Revue Méd. Vét., 2013, 164, 1, 18-22


22 PETROV (V.) AND COLLABORATORS

7. GREENE C.E.: Otitis Externa. In: Infectious diseases of 15. OLIVEIRA L.C., LEITE C.A, BRILHANTE R.S.,
the dog and cat, Greene CE (ed), 3rd edition, Saunders, CARVALHO C.B.: Comparative study of the microbial
Missouri, 2006, pp.: 815-823. proile from bilateral canine otitis externa. Can. Vet. J.,
8. HARIHARAN H., COLES M., POOLE D., LUND L., 2008, 49, 785-788.
PAGE R.: Update on antimicrobial susceptibility of 16. QUINN P.J., CARTER M.E., MARKEY B.: Section:
bacterial isolates from canine and feline otitis externa. 2 Bacteriology. In: Clinical Veterinary Microbiology.
Can. Vet. J., 2006, 47, 253-255. Harcourt Publishers Limited, 1999, pp.: 118-254.
9. HARVEY R.G., HARARI J., DELAUCHE A.J.: Ear 17. ROSSER E.J.: Causes of otitis externa. Vet. Clin. Small
diseases of the dog and cat. Chapter VII: Medical Anim., 2004, 34, 459-468.
management of ear disease. Nohrtcott J. (ed.), Manson 18. SCOTT D.W., MILLER W.H., GRIFFIN C.E.: Otitis, In:
Publishing, London, 2001, pp.: 161-212. Muller and Kirk’s Small Animal Dermatology. Saunders,
10. KROGH H.V., LINNET A., KNUDSEN P.B.: Otitis Philadelphia, 2001, pp.: 143-148.
externa in the dog -a clinical and microbiological study. 19. VANNI M., TOGNETTI R., PRETTI C., CREMA F.,
Nord. Vet. Med., 1975, 27, 285-295. SOLDANI G., MEUCCI V., INTORRE L.: Antimicrobial
11. LILENBAUM W., AQUINO M.H.C., COSTA M.N.A., susceptibility of Staphylococcus intermedius and
SOUZA NETTO B.A., SOUZA E.T.: Bacterial otitis in Staphylococcus schleiferi isolated from dogs. Res. Vet.
dogs. Med. Sci., 1987, 6, 47-52. Sci., 2009, 87, 192-195.
12. LYSKOVA P., VYDRZALOVA M., MAZUROVA 20. WILDERMUTH B.E., GRIFFIN C.E, ROSENKRANTZ
J.: Identiication and antimicrobial susceptibility of W.S., BOORD M.J.: Susceptibility of Pseudomonas
bacteria and yeasts isolated from healthy dogs and dogs isolates from the ears and skin of dogs to Enroloxacin,
with otitis externa. J. Vet. Med. A Physiol. Pathol. Clin. marboloxacin, and ciproloxacin. J. Am. Anim. Hosp.
Med., 2007, 54, 559-563. Assoc., 2007, 43, 337-341.
13. MARTIN BARRASA J.L., LUPIOLA GOMEZ P., 21. ZAMANKHAN M.H., JAMSHIDI S., ZAHRAEI S.:
GONZALEZ LAMA Z., TEJEDOR JUNCO M.T.: Identiication and antimicrobial susceptibility patterns
Antibacterial susceptibility patterns of Pseudomonas of bacteria causing otitis externa in dogs. Vet. Res.
strains isolated from chronic otitis externa. J. Vet. Med. Comm., 2010, 34, 435-444.
B, 2000, 47, 191-196.
14. NCCLSI (National Committee for Clinical Laboratory
Standard Institute): National committee for clinical and
laboratory standards and methods for antimicrobial
susceptibility testing of anaerobic bacteria, Approved
standard, 6th edition, NCCLS, Wayne, PA, 2004,
Document M11-A6.

Revue Méd. Vét., 2013, 164, 1, 18-22

You might also like